Vaccines to methamphetamine (meth) were designed by covalently attaching a meth hapten (METH) to peptide constructs that contained a conformationally biased, response-selective molecular adjuvant, YSFKPMPLaR (EP54). Rats immunized with EP54-containing meth vaccines generated serum antibody titers to authentic meth, an immune outcome that altered meth self-administration. Immunization increased ...

Introduction: Methamphetamine (METH) is a neurotoxic psychostimulant with highly addictive potential that leads to compulsive drug use and vulnerability to relapse. Environmental cues, such as drug exposure, peer influence, and social stress, are the powerful triggers of drug relapse. In  this  study,  we  tried  to  find  out  the effect of acute and chr...

Abstract Chronic exposure to methamphetamine (METH) causes severe and persistent cognitive impairment. The present study aimed investigate the role of dynorphin/κ opioid receptor (KOR) system in development METH‐induced We found that mice showed significant impairment novel object recognition test (NOR) following daily injections METH (10 mg/kg) for seven consecutive days. Systemic blockade KOR...

Introduction: In this study, we investigated whether neurofeedback (NFB) training and swimming exercise would decrease the electroencephalographic (EEG) changes visual image-induced craving in methamphetamine (METH)-dependent patients. Methods: This study was a randomized controlled trial design. 32 METH-dependent patients were allocated randomly to four groups; control, NFB, Swim, NFB/Swim. Th...

Methamphetamine (Meth) is a widely abuse psychostimulant. Traditionally, studies have focused on the neurotoxic effects of Meth on monoaminergic neurotransmitter terminals. Recently, both in vitro and in vivo studies have investigated the effects of Meth on the BBB and found that Meth produces a decrease in BBB structural proteins and an increase in BBB permeability to various molecules. Moreov...

Previous studies have demonstrated that the effects of methamphetamine (METH) on dopaminergic and serotonergic systems are likely related to METH-induced increases in dopamine release. The ability of haloperidol to prevent these effects of METH suggests that dopamine receptor activation is involved in mediating these METH actions. The present studies were undertaken to determine what role the d...